Results 171 to 180 of about 1,453,231 (297)

Enhanced harm detection following maternal separation: Transgenerational transmission and reversibility by inhaled amiloride. [PDF]

open access: yesSci Adv, 2023
Battaglia M   +6 more
europepmc   +1 more source

Setting up mother–infant pair lactation studies with biobanking for research according to regulatory requirements

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Within the ConcePTION project we set out to design two mother–infant pair studies collecting breast milk and plasma from the mother and plasma from the infant (for metformin and prednisolone) in order to demonstrate the premises and conditions for investigating potential drug transfer in association with breastfeeding.
Mats Hansson   +11 more
wiley   +1 more source

Maternal separation and its developmental consequences on anxiety and parvalbumin interneurons in the amygdala. [PDF]

open access: yesJ Neural Transm (Vienna), 2023
Abraham M   +5 more
europepmc   +1 more source

Maternal separation differentially modulates early pathology by sex in 5xFAD Alzheimer's disease-transgenic mice. [PDF]

open access: yesBrain Behav Immun Health, 2023
Garcia MG   +6 more
europepmc   +1 more source

The quantification and epistemology of medicines use and polypharmacy tested in an observational study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Definitions of ‘medicines use’ and ‘polypharmacy’ may refer to all medicines, regular long‐term medicines or another subset. Valid definitions of medicines use should incorporate type of use (long term, short course and as needed [PRN]), changes in use (start, stop and dose change) and a description of temporal examination (cross‐sectional or ...
Lorna Pairman, Paul Chin, Matthew Doogue
wiley   +1 more source

Dysfunction of the paraventricular thalamus-prelimbic cortex circuit underlies maternal separation-induced deficits in contagious pain. [PDF]

open access: yesSci Adv
Zhang Z   +17 more
europepmc   +1 more source

Plasma and breast milk pharmacokinetics of suvorexant in healthy lactating women

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim This paper aims to evaluate the plasma and breast milk pharmacokinetics of suvorexant, an orexin receptor antagonist used to treat insomnia at a maximum dose of 20 mg, in healthy lactating women. Methods The paper reports on an open‐label Phase 1 study in 12 healthy lactating women.
Jacqueline McCrea   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy